These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Delayed action of intramuscular and subcutaneous injectable heparines]. Busch H; Thürmann D Med Welt; 1971 Oct; 44():1760-1. PubMed ID: 5125844 [No Abstract] [Full Text] [Related]
43. Subcutaneous compared with intravenous heparin for deep vein thrombosis. Young MA Ann Intern Med; 1992 Aug; 117(3):265; author reply 265-6. PubMed ID: 1616226 [No Abstract] [Full Text] [Related]
44. Widespread skin necrosis associated with unfractionated heparin therapy in a patient under chronic coumarin anticoagulation. Sanchez-Politta S; Angelillo-Scherrer A; Masouyé I; Borradori L J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):327-30. PubMed ID: 16503898 [TBL] [Abstract][Full Text] [Related]
45. Regulation of heparin therapy. Deykin D N Engl J Med; 1972 Aug; 287(7):355-6. PubMed ID: 5041705 [No Abstract] [Full Text] [Related]
46. Editorial: Low-dose heparin prophylaxis for postoperative venous thromboembolism. Sherry S N Engl J Med; 1975 Aug; 293(6):300-2. PubMed ID: 1138184 [No Abstract] [Full Text] [Related]
48. [Complex treatment of thrombosis of retinal veins and its effectiveness]. Cherkasov IS; Nakhabina TP Oftalmol Zh; 1973; 28(5):365-9. PubMed ID: 4272973 [No Abstract] [Full Text] [Related]
49. Subcutaneous or intravenous heparin for deep vein thrombosis. Bounameaux H; Krahenbuhl B Br Med J (Clin Res Ed); 1987 Jun; 294(6588):1690-1. PubMed ID: 3113593 [No Abstract] [Full Text] [Related]
50. [Prevention of the recurrences of deep venous thromboses of the legs using calcium heparin in slowly decreasing dosages]. Bilancini S; Lucchi M Angiologia; 1988; 40(4):125-8. PubMed ID: 3177941 [No Abstract] [Full Text] [Related]
51. Surreptitious self-administration of heparin. Martin CM; Engstrom PF; Barrett O JAMA; 1970 Apr; 212(3):475-6. PubMed ID: 5467299 [No Abstract] [Full Text] [Related]
53. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin. Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312 [TBL] [Abstract][Full Text] [Related]
54. [Subcutaneous heparin for the management of hypercoagulability]. von Kaulla KN; von Kaulla E Dtsch Med Wochenschr; 1969 May; 94(19):985-9. PubMed ID: 5779813 [No Abstract] [Full Text] [Related]
55. Antithrombin III in patients treated with subcutaneous or intravenous heparin. Conard J; Lecompte T; Horellou MH; Cazenave B; Samama M Thromb Res; 1981 May; 22(4):507-11. PubMed ID: 7292454 [No Abstract] [Full Text] [Related]
56. Comparison at the clinical level of different types and routes of heparin administration. Bouvier CA Scand J Haematol Suppl; 1980; 36():91-100. PubMed ID: 6935764 [No Abstract] [Full Text] [Related]
57. Hormones and sudden deafness. Schiff M; Brown M Laryngoscope; 1974 Nov; 84(11):1959-81. PubMed ID: 4373627 [No Abstract] [Full Text] [Related]
58. A train difference in anticoagulant response to subcutaneous administration of heparin in mice. Sue TK; Jaques LB; Yelland J Thromb Res; 1978 Jan; 12(1):5-13. PubMed ID: 644560 [No Abstract] [Full Text] [Related]
59. The observation of heparin on endothelium after injection. Hiebert LM; Jaques LB Thromb Res; 1976 Feb; 8(2):195-204. PubMed ID: 1251350 [No Abstract] [Full Text] [Related]
60. Thromboelastographic evaluation of the method of heparin administration. Rosato FE; Rosato EF; Roberts B; Kinsley RF Am J Surg; 1967 Jun; 113(6):750-3. PubMed ID: 6023909 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]